info787351Apr 3, 20122 min readAntibiotics Developer BioRelix Inc. Secures Follow-on Investment from Connecticut InnovationsConnecticut Innovations (CI), the state’s quasi-public authority responsible for technology-based innovation and economic development,...
info787351Jan 23, 20122 min readBioRelix Inc. Secures $500,000 Investment from Connecticut InnovationsAntibiotics developer utilizes novel riboswitch-based drug discovery platform Connecticut Innovations (CI), the state’s quasi-public...